University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments
Status: Grey Durvalumab
Status: Amber Dutasteride capsules

RICaD

Status: Red Econazole pessaries (Gyno-Pevaryl®)
Status: Red Eculizumab (Bekemv®)
Status: Green Edoxaban

Second choice following diagnosis of AF- use in line with NICE.

Status: Amber Edoxaban#Amber

Specialist initiation - For the treatment and secondary prevention of DVT and/or PE - use in line with NICE and supported by RICaD

Status: Red Edrophonium chloride
Status: Red Efanesoctocog alfa (ALTUVOCT®)
Status: Red Elafibranor (Iqirvo®)
Status: Red Eliglustat (Cerdelga®)

NHSE commissioned

Building healthier lives
Back to top